To improve the detection of ovarian cancer at an early stage over CA125 alone, we used a statistical learning method to develop a multiprotein classifier that could distinguish sera from early stage ovarian cancer patients from that of healthy control women. This evidence concerns the gene MUC16 and ovarian cancer.